Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 32Neoplasms 26Depression 21Fatigue 20Prostatic Neoplasms 13Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Multiple Myeloma 11Lymphoma, Large B-Cell, Diffuse 10Lung Neoplasms 10Colorectal Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pain 9Lymphoma, Non-Hodgkin 9Lymphoma, Mantle-Cell 9Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 9Burkitt Lymphoma 9Anxiety Disorders 9Vomiting 7Nausea 7Leukemia, Myeloid, Acute 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Head and Neck Neoplasms 7Carcinoma, Ovarian Epithelial 7Blast Crisis 7

Interventions

Dexamethasone 3Acupuncture Therapy 2ramosetron 1phenazine 1esmolol 1Therapeutics 1Surveys and Questionnaires 1Promethazine 1Ondansetron 1Olanzapine 1Fentanyl 1Famotidine 1Electric Stimulation Therapy 1Electric Stimulation 1Diphenhydramine 1Dexmedetomidine 1Calcium Dobesilate 1Antiemetics 1Anesthesia, General 1Analgesics, Opioid 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Postoperative Nausea and Vomiting × Therapeutics × Clear all
NCT03631004 2022-01-13

Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients

Instituto do Cancer do Estado de São Paulo

Phase 2/3 Completed
100 enrolled

Nausea, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡